Cover Image
市场调查报告书

全球子宫颈癌检验市场及患者的预测:抹片检查,HPV DNA,VIA - 19个国家的市场分析与预测

Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA), 19 Countries Analysis & Forecast

出版商 Renub Research 商品编码 298601
出版日期 内容信息 英文 309 Pages
商品交期: 最快1-2个工作天内
价格
Back to Top
全球子宫颈癌检验市场及患者的预测:抹片检查,HPV DNA,VIA - 19个国家的市场分析与预测 Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA), 19 Countries Analysis & Forecast
出版日期: 2018年05月23日 内容信息: 英文 309 Pages
简介

全球子宫颈癌筛检市场规模,预计至2024年达到约70亿美元。子宫颈癌多为30岁以上的女性罹患,主要由人类乳突病毒 (HPV) 病毒引起。子宫颈癌,是女性第4大罹患的癌症,在全部的癌症中,是第7大发病率高的疾病。

本报告提供全球子宫颈癌检验市场相关调查,子宫颈癌检验人口与预测,子宫颈癌的死亡率,各检查 (抹片检查、HPV DNA、VIA)的市场预测,及主要国家的市场预测等。

第1章 摘要整理

第2章 全球子宫颈癌检验 (筛检) 人口、预测

  • 亚洲
  • 欧洲
  • 北美
  • 其他地区

第3章 全球子宫颈癌检验 (筛检) 市场、预测

  • 子宫颈抹片检验
  • HPV DNA检验
  • 醋酸 (VIA) 检验的子宫颈癌的目测检验

第4章 全球子宫颈癌检验 (筛检) 市场分析:各地区

  • 亚洲
  • 欧洲
  • 北美
  • 其他地区

第5章 全球子宫颈癌检验 (筛检) 人口占有率、预测

  • 各地区
  • 各国

第6章 全球子宫颈癌检验 (筛检) 市场占有率、预测

  • 各地区:子宫颈癌检验
  • 各国:子宫颈癌检验
  • 各国:子宫颈抹片检验
  • 各国:HPV DNA检验
  • 各国:VIA检验

第7章 英国市场分析

第8章 法国市场分析

第9章 德国市场分析

第10章 义大利市场分析

第11章 西班牙市场分析

第12章 瑞典市场分析

第13章 瑞士市场分析

第14章 挪威市场分析

第15章 荷兰市场分析

第16章 美国市场分析

第17章 加拿大市场分析

第18章 日本市场分析

第19章 韩国市场分析

第20章 新加坡市场分析

第21章 马来西亚市场分析

第22章 印度市场分析

第23章 中国市场分析

第24章 泰国市场分析

第25章 印尼市场分析

第26章 其他地区市场分析

第27章 子宫颈癌市场促进成长要素

第28章 子宫颈癌市场上课题

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录

Global Cervical Cancer Screening Market is projected to reach US$ 7 Billion by the year 2024. Cervical cancer affects the lower part of the uterus (womb). Cervical cancer generally occurs in women over 30 years. It is mostly caused by the Human Papillomavirus (HPV) Virus. Cervical cancer is the fourth most common cancer prevailing in women and the seventh in terms of overall cancer incidences.

Increasing cervical cancer prevalence rate is one of the key factors that drive the cervical cancer screening market. Rapidly increasing female population, growing incidence of HPV infections and increasing awareness about cervical cancer screening programs is also expected to drive the cervical cancer screening market in the near future.

Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA), 19 Countries Analysis & Forecast is a market research report published by Renub Research. The report provides a complete analysis of Global Cervical Cancer Test Market, Screened Population & Mortality.

By Test Types - VIA Screening Tests is Gaining Popularity in Developing Countries

The report studies the market and population of the following cervical cancer screening tests: Pap smear Tests, HPV DNA Tests and VIA Tests. Pap smear and HPV DNA tests are more popular with the developed countries such as United States, Germany, United Kingdom and Others.

By Region - Asian Region is Expected to Grow Steadily during the Forecast Period

North America and Europe together dominates the Cervical Cancer Screening Market. In addition; the report also provides the complete geographical analysis of Asian and Rest of World, cervical cancer screening market.

By Country - Japan is expected to witness a slight decline in Cervical Cancer Screening Market in near Future

The report studies the market/screened population of 19 countries, which provides a complete country-wise analysis of Global Cervical Cancer Screening Market. All the 19 countries are as follows: United Kingdom, India, France, Japan, Italy, China, Sweden, Malaysia, Norway, Canada, Netherlands, Korea, United States, Germany, Switzerland, Singapore, Spain, Thailand and Indonesia

The report ‘Cervical Cancer Screening Market' have been studied from 3 major viewpoints

Cervical Cancer Screening Market

  • Pap Smear Tests Market
  • HPV DNA Tests Market
  • VIA Tests Market

Cervical Cancer Test Population

  • Pap Smear Test Population
  • HPV DNA Test Population
  • VIA Test Population

Client can purchase this report in sections through Purchase by Chapter Tab given above

Cervical Cancer Mortality Population

In this section number of deaths by cervical cancer in all the 19 countries from 2011 to 2017 has been captured.

All the 19 Countries Studied in the Report are as Follows:

  • 1. United Kingdom
  • 2. France
  • 3. Germany
  • 4. Italy
  • 5. Spain
  • 6. Sweden
  • 7. Switzerland
  • 8. Norway
  • 9. Netherlands
  • 10. United States
  • 11. Canada
  • 12. Japan
  • 13. Korea
  • 14. Singapore
  • 15. Malaysia
  • 16. India
  • 17. China
  • 18. Thailand
  • 19. Indonesia

Key Questions Answered in the Report?

  • What will be the Cervical Cancer Screening Market by 2024?
  • How many women will be screened for Cervical Cancer in the recent future?
  • Which country has the maximum and least market share in Cervical Cancer Screening Market?
  • What will be the Pap Smear Screening Tests Market by 2024?
  • What will be the HPV DNA Screening Tests Market by 2024?
  • In which Region, Visual Inspection with Acetic Acid (VIA) Screening Tests is growing.
  • How many deaths have occurred due to cervical cancer in each country from 2011 to 2017

Table of Contents

1. Executive Summary

2. Global Cervical Cancer Test (Screening) Population (2011-2024)

  • 2.1. Asia
  • 2.2. Europe
  • 2.3. North America
  • 2.4. Rest of World

3. Global Cervical Cancer Test (Screening) Market (2011-2024)

  • 3.1. Pap Smear Test (Screening)
  • 3.2. HPV DNA Test (Screening)
  • 3.3. Visual Inspection with Acetic Acid (VIA) Test (Screening)

4. By Region-Global Cervical Cancer Test (Screening) Market Analysis (2011-2024)

  • 4.1. Asia
  • 4.2. Europe
  • 4.3. North America
  • 4.4. Rest of World

5. Population Share-Global Cervical Cancer Test (Screening) (2011-2024)

  • 5.1. Region
  • 5.2. Countries

6. Market Share-Global Cervical Cancer Test (Screening) (2011-2024)

  • 6.1. Region-Cervical Cancer Test (Screening)
  • 6.2. Countries-Cervical Cancer Test (Screening)
  • 6.3. Countries-Pap Smear Test (Screening)
  • 6.4. Countries-HPV DNA Test (Screening)
  • 6.5. Countries-VIA Test (Screening)

7. United Kingdom-Cervical Cancer Test Analysis (2011-2024)

  • 7.1. Population-Cervical Cancer Test
    • 7.1.1. Pap Smear Test Population
    • 7.1.2. HPV DNA Test Population
  • 7.2. United Kingdom Cervical Cancer Deaths
  • 7.3. Market-Cervical Cancer Test (Screening)
    • 7.3.1. Pap Smear Test Market
    • 7.3.2. HPV DNA Test Market

8. France-Cervical Cancer Test Analysis (2011-2024)

  • 8.1. Population-Cervical Cancer Test (Screening)
    • 8.1.1. Pap smear Test Population
    • 8.1.2. HPV DNA Test Population
  • 8.2. France Cervical Cancer Mortality
  • 8.3. Market-Cervical Cancer Test (Screening)
    • 8.3.1. Pap Smear Test Market
    • 8.3.2. HPV DNA Test Market

9. Germany-Cervical Cancer Test Analysis (2011-2024)

  • 9.1. Population-Cervical Cancer Test (Screening)
    • 9.1.1. Pap Smear Test Population
    • 9.1.2. HPV DNA Test Population
  • 9.2. Germany Cervical Cancer Mortality
  • 9.3. Market-Cervical Cancer Test (Screening)
    • 9.3.1. Pap Smear Test Market
    • 9.3.2. HPV DNA Test Market & Forecast

10. Italy-Cervical Cancer Test Analysis (2011-2024)

  • 10.1. Population-Cervical Cancer Test (Screening)
    • 10.1.1. Pap smear Test Population
    • 10.1.2. HPV DNA Test Population
  • 10.2. Italy Cervical Cancer Mortality
  • 10.3. Market-Cervical Cancer Test (Screening)
    • 10.3.1. Pap Smear Test Market
    • 10.3.2. HPV DNA Test Market

11. Spain-Cervical Cancer Test Analysis (2011-2024)

  • 11.1. Population-Cervical Cancer Test (Screening)
    • 11.1.1. Pap Smear Test Population
    • 11.1.2. HPV DNA Test Population
  • 11.2. Spain Cervical Cancer Mortality
  • 11.3. Market-Cervical Cancer Test (Screening)
    • 11.3.1. Pap Smear Test Market
    • 11.3.2. HPV DNA Test Market

12. Sweden-Cervical Cancer Test Analysis

  • 12.1. Population-Cervical Cancer Test (Screening)
    • 12.1.1. Pap smear Test Population
    • 12.1.2. HPV DNA Test Population
  • 12.2. Sweden Cervical Cancer Mortality
  • 12.3. Market-Cervical Cancer Test (Screening)
    • 12.3.1. Pap Smear Test Market
    • 12.3.2. HPV DNA Test Market

13. Switzerland-Cervical Cancer Test Analysis

  • 13.1. Population-Cervical Cancer Test (Screening)
    • 13.1.1. Pap smear Test Population
    • 13.1.2. HPV DNA Test Population
  • 13.2. Switzerland Cervical Cancer Mortality
  • 13.3. Market-Cervical Cancer Test (Screening)
    • 13.3.1. Pap Smear Test Market
    • 13.3.2. HPV DNA Test Market

14. Norway-Cervical Cancer Test Analysis

  • 14.1. Population-Cervical Cancer Test (Screening)
    • 14.1.1. Pap smear Test Population
    • 14.1.2. HPV DNA Test Population
  • 14.2. Norway Cervical Cancer Mortality
  • 14.3. Market-Cervical Cancer Test (Screening)
    • 14.3.1. Pap Smear Test Market
    • 14.3.2. HPV DNA Test Market

15. Netherlands-Cervical Cancer Test Analysis

  • 15.1. Population-Cervical Cancer Test (Screening)
    • 15.1.1. Pap smear Test Population
    • 15.1.2. HPV DNA Test Population
  • 15.2. Netherlands Cervical Cancer Mortality
  • 15.3. Market-Cervical Cancer Test (Screening)
    • 15.3.1. Pap Smear Test Market
    • 15.3.2. HPV DNA Test Market

16. United States-Cervical Cancer Test Analysis

  • 16.1. Population-Cervical Cancer Test (Screening)
    • 16.1.1. Pap smear Test Population
    • 16.1.2. HPV DNA Test Population
  • 16.2. United States Cervical Cancer Mortality
  • 16.3. Market-Cervical Cancer Test (Screening)
    • 16.3.1. Pap Smear Test Market
    • 16.3.2. HPV DNA Test Market

17. Canada-Cervical Cancer Test Analysis

  • 17.1. Population-Cervical Cancer Test (Screening)
    • 17.1.1. Pap smear Test Population
    • 17.1.2. HPV DNA Test Population
  • 17.2. Canada Cervical Cancer Mortality
  • 17.3. Market-Cervical Cancer Test (Screening)
    • 17.3.1. Pap Smear Test Market
    • 17.3.2. HPV DNA Test Market

18. Japan-Cervical Cancer Test Analysis

  • 18.1. Population-Cervical Cancer Test (Screening)
    • 18.1.1. Pap smear Test Population
    • 18.1.2. HPV DNA Test Population
  • 18.2. Japan Cervical Cancer Mortality
  • 18.3. Market-Cervical Cancer Test (Screening)
    • 18.3.1. Pap Smear Test Market
    • 18.3.2. HPV DNA Test Market

19. South Korea-Cervical Cancer Tests Analysis

  • 19.1. Population-Cervical Cancer Test (Screening)
    • 19.1.1. Pap smear Test Population
    • 19.1.2. HPV DNA Test Population
  • 19.2. Korea Cervical Cancer Mortality
  • 19.3. Market-Cervical Cancer Test (Screening)
    • 19.3.1. Pap Smear Test Market
    • 19.3.2. HPV DNA Test Market

20. Singapore-Cervical Cancer Tests Analysis

  • 20.1. Population-Cervical Cancer Test (Screening)
    • 20.1.1. Pap smear Test Population
    • 20.1.2. HPV DNA Test Population
  • 20.2. Market-Cervical Cancer Test (Screening)
    • 20.2.1. Pap Smear Test Market
    • 20.2.2. HPV DNA Test Market

21. Malaysia-Cervical Cancer Test Analysis

  • 21.1. Population-Cervical Cancer Test (Screening)
    • 21.1.1. Pap smear Test Population
    • 21.1.2. HPV DNA Test Population
  • 21.2. Market-Cervical Cancer Test (Screening)
    • 21.2.1. Pap Smear Test Market
    • 21.2.2. HPV DNA Test Market

22. India-Cervical Cancer Test Analysis

  • 22.1. Population-Cervical Cancer Test (Screening)
    • 22.1.1. Pap smear Test Population
    • 22.1.2. HPV DNA Test Population
    • 22.1.3. Cervical Cancer VIA Test Population & Forecast
  • 22.2. Market-Cervical Cancer Test (Screening)
    • 22.2.1. Pap Smear Test Market
    • 22.2.2. HPV DNA Test Market
    • 22.2.3. VIA Test Market & Forecast

23. China-Cervical Cancer Test Analysis

  • 23.1. Population-Cervical Cancer Test (Screening)
    • 23.1.1. Pap smear Test Population
    • 23.1.2. HPV DNA Test Population
    • 23.1.3. Cervical Cancer VIA Test Population & Forecast
  • 23.2. Market-Cervical Cancer Test (Screening)
    • 23.2.1. Pap Smear Test Market
    • 23.2.2. HPV DNA Test Market
    • 23.2.3. VIA Test Market & Forecast

24. Thailand-Cervical Cancer Test Analysis

  • 24.1. Population-Cervical Cancer Test (Screening)
    • 24.1.1. Pap smear Test Population
    • 24.1.2. Cervical Cancer VIA Test Population & Forecast
  • 24.2. Market-Cervical Cancer Test (Screening)
    • 24.2.1. Pap Smear Test Market
    • 24.2.2. VIA Test Market & Forecast

25. Indonesia-Cervical Cancer Test Analysis

  • 25.1. Population-Cervical Cancer Test (Screening)
    • 25.1.1. Pap smear Test Population
    • 25.1.2. HPV DNA Test Population
    • 25.1.3. Cervical Cancer VIA Test Population & Forecast
    • 25.1.4. Indonesia Cervical Cancer Both (Pap smear & VIA) Test Population & Forecast
  • 25.2. Market-Cervical Cancer Test (Screening)
    • 25.2.1. Pap Smear Test Market
    • 25.2.2. HPV DNA Test Market
    • 25.2.3. VIA Test Market
    • 25.2.4. Indonesia Cervical Cancer Both (Pap smear & VIA) Test Market & Forecast

26. Rest of World-Cervical Cancer Test Analysis

  • 26.1. Population-Cervical Cancer Test (Screening)
    • 26.1.1. Pap smear Test Population
    • 26.1.2. HPV DNA Test Population
  • 26.2. Market-Cervical Cancer Test (Screening)
    • 26.2.1. Pap Smear Test Market
    • 26.2.2. HPV DNA Test Market

27. Cervical Cancer Test Market Growth Drivers

  • 27.1. Introduction of Low Cost VIA Test
    • 27.1.1. Countries Offering VIA Test via National Programs
    • 27.1.2. Countries Offering VIA Test via Pilot Programs
  • 27.2. Worldwide High Prevalence of HPV Infected Patients
  • 27.3. Rising Number of Incidence of Cervical Cancer in United Kingdom
  • 27.4. Worldwide Rising Incidence of Teenage Sexual Cases

28. Challenges in Cervical Cancer Test Market

  • 28.1. Lack of Appropriate Healthcare Infrastructure
  • 28.2. Introduction of HPV Vaccination Programs Worldwide

List of Figures:

  • Figure 2-1: Global - Cervical Cancer Test Population (Million), 2011 - 2017
  • Figure 2-2: Global - Forecast for Cervical Cancer Test Population (Million), 2018 - 2024
  • Figure 2-3: Asia - Cervical Cancer Test Population (Million), 2011 - 2017
  • Figure 2-4: Asia - Forecast for Cervical Cancer Test Population (Million), 2018 - 2024
  • Figure 2-5: Europe - Cervical Cancer Test Population (Million), 2011 - 2017
  • Figure 2-6: Europe - Forecast for Cervical Cancer Test Population (Million), 2018 - 2024
  • Figure 2-7: North America - Cervical Cancer Test Population (Million), 2011 - 2017
  • Figure 2-8: North America - Forecast for Cervical Cancer Test Population (Million), 2018 - 2024
  • Figure 3-1: Global - Cervical Cancer Test Market (Million US$), 2011 - 2017
  • Figure 3-2: Global - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2024
  • Figure 3-3: Global - Cervical Cancer Pap Smear Test Market (Million US$), 2011 - 2017
  • Figure 3-4: Global - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2018 - 2024
  • Figure 3-5: Global - Cervical Cancer HPV DNA Test Market (Million US$), 2011 - 2017
  • Figure 3-6: Global - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2018 - 2024
  • Figure 3-7: Global - Cervical Cancer VIA Test Market (Million US$), 2011 - 2017
  • Figure 3-8: Global - Forecast for Cervical Cancer VIA Test Market (Million US$), 2018 - 2024
  • Figure 4-1: Asia - Cervical Cancer Test Market (Million US$), 2011 - 2017
  • Figure 4-2: Asia - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2024
  • Figure 4-3: Europe - Cervical Cancer Test Market (Million US$), 2011 - 2017
  • Figure 4-4: Europe - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2024
  • Figure 4-5: North America - Cervical Cancer Test Market (Million US$), 2011 - 2017
  • Figure 4-6: North America - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2024
  • Figure 5-1: Global - Cervical Cancer Test (Screening) Population Share (Percent) by Region, 2011 - 2017
  • Figure 5-2: Global - Forecast for Cervical Cancer Test (Screening) Population Share (Percent) by Region, 2018 - 2024
  • Figure 6-1: Global - Cervical Cancer Market Share (Percent) By Region, 2011 - 2017
  • Figure 6-2: Global - Forecast for Cervical Cancer Market Share (Percent) By Region, 2018 - 2024
  • Figure 7-1: United Kingdom - Cervical Cancer Test Population (Thousand), 2011 - 2017
  • Figure 7-2: United Kingdom - Forecast for Cervical Cancer Test Population (Thousand), 2018 - 2024
  • Figure 7-3: United Kingdom - Cervical Cancer Pap Smear Test Population (Thousand), 2011 - 2017
  • Figure 7-4: United Kingdom - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 - 2024
  • Figure 7-5: United Kingdom - Cervical Cancer HPV DNA Test Population (Thousand), 2011 - 2017
  • Figure 7-6: United Kingdom - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 - 2024
  • Figure 7-7: United Kingdom - Cervical Cancer Deaths (Number), 2011 - 2017
  • Figure 7-8: United Kingdom - Cervical Cancer Test Market (Million US$), 2011 - 2017
  • Figure 7-9: United Kingdom - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2024
  • Figure 7-10: United Kingdom - Pap Smear Test Market (Million US$), 2011 - 2017
  • Figure 7-11: United Kingdom - Forecast for Pap Smear Test Market (Million US$), 2018 - 2024
  • Figure 7-12: United Kingdom - HPV DNA Test Market (Million US$), 2011 - 2017
  • Figure 7-13: United Kingdom - Forecast for HPV DNA Test Market (Million US$), 2018 - 2024
  • Figure 8-1: France - Cervical Cancer Test Population (Thousand), 2011 - 2017
  • Figure 8-2: France - Forecast for Cervical Cancer Test Population (Thousand), 2018 - 2024
  • Figure 8-3: France - Cervical Cancer Pap Smear Test Population (Thousand), 2011 - 2017
  • Figure 8-4: France - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 - 2024
  • Figure 8-5: France - Cervical Cancer HPV DNA Test Population (Thousand), 2011 - 2017
  • Figure 8-6: France - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 - 2024
  • Figure 8-7: France - Cervical Cancer Mortality (Number), 2011 - 2017
  • Figure 8-8: France - Cervical Cancer Test Market (Million US$), 2011 - 2017
  • Figure 8-9: France - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2024
  • Figure 8-10: France - Pap Smear Test Market (Million US$), 2011 - 2017
  • Figure 8-11: France - Forecast for Pap Smear Test Market (Million US$), 2018 - 2024
  • Figure 8-12: France - HPV DNA Test Market (Million US$), 2011 - 2017
  • Figure 8-13: France - Forecast for HPV DNA Test Market (Million US$), 2018 - 2024
  • Figure 9-1: Germany - Cervical Cancer Test Population (Thousand), 2011 - 2017
  • Figure 9-2: Germany - Forecast for Cervical Cancer Test Population (Thousand), 2018 - 2024
  • Figure 9-3: Germany - Cervical Cancer Pap Smear Test Population (Thousand), 2011 - 2017
  • Figure 9-4: Germany - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 - 2024
  • Figure 9-5: Germany - Cervical Cancer HPV DNA Test Population (Thousand), 2011 - 2017
  • Figure 9-6: Germany - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 - 2024
  • Figure 9-7: Germany - Cervical Cancer Mortality (Number), 2011 - 2017
  • Figure 9-8: Germany - Cervical Cancer Test Market (Million US$), 2011 - 2017
  • Figure 9-9: Germany - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2024
  • Figure 9-10: Germany - Pap Smear Test Market (Million US$), 2011 - 2017
  • Figure 9-11: Germany - Forecast for Pap Smear Test Market (Million US$), 2018 - 2024
  • Figure 9-12: Germany - HPV DNA Test Market (Million US$), 2011 - 2017
  • Figure 9-13: Germany - Forecast for HPV DNA Test Market (Million US$), 2018 - 2024
  • Figure 10-1: Italy - Cervical Cancer Test Population (Thousand), 2011 - 2017
  • Figure 10-2: Italy - Cervical Cancer Test Population (Thousand), 2018 - 2024
  • Figure 10-3: Italy - Cervical Cancer Pap Smear Test Population (Thousand), 2011 - 2017
  • Figure 10-4: Italy - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2017 - 2024
  • Figure 10-5: Italy - Cervical Cancer HPV DNA Test Population (Thousand), 2011 - 2017
  • Figure 10-6: Italy - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 - 2024
  • Figure 10-7: Italy - Cervical Cancer Mortality (Number), 2011 - 2017
  • Figure 10-8: Italy - Cervical Cancer Test Market (Million US$), 2011 - 2017
  • Figure 10-9: Italy - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2024
  • Figure 10-10: Italy - Pap Smear Test Market (Million US$), 2011 - 2017
  • Figure 10-11: Italy - Forecast for Pap Smear Test Market (Million US$), 2018 - 2024
  • Figure 10-12: Italy - HPV DNA Test Market (Million US$), 2011 - 2017
  • Figure 10-13: Italy - Forecast for HPV DNA Test Market (Million US$), 2018 - 2024
  • Figure 11-1: Spain - Cervical Cancer Test Population (Thousand), 2011 - 2017
  • Figure 11-2: Spain - Forecast for Cervical Cancer Test Population (Thousand), 2018 - 2024
  • Figure 11-3: Spain - Cervical Cancer Pap Smear Test Population (Thousand), 2011 - 2017
  • Figure 11-4: Spain - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 - 2024
  • Figure 11-5: Spain - Cervical Cancer HPV DNA Test Population (Thousand), 2011 - 2017
  • Figure 11-6: Spain - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 -2024
  • Figure 11-7: Spain - Cervical Cancer Mortality (Number), 2011 - 2017
  • Figure 11-8: Spain - Cervical Cancer Test Market (Million US$), 2011 - 2017
  • Figure 11-9: Spain - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2024
  • Figure 11-10: Spain - Pap Smear Test Market (Million US$), 2011 - 2017
  • Figure 11-11: Spain - Forecast for Pap Smear Test Market (Million US$), 2018 - 2024
  • Figure 11-12: Spain - HPV DNA Test Market (Million US$), 2011 - 2017
  • Figure 11-13: Spain - Forecast for HPV DNA Test Market (Million US$), 2018 - 2024
  • Figure 12-1: Sweden - Cervical Cancer Pap Smear Test Population (Thousand), 2011 - 2017
  • Figure 12-2: Sweden - Forecast for Cervical Cancer Pap smear Test Population (Thousand), 2018 - 2024
  • Figure 12-3: Sweden - Cervical Cancer Pap Smear Test Population (Thousand), 2011 - 2017
  • Figure 12-4: Sweden - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 - 2024
  • Figure 12-5: Sweden - Cervical Cancer HPV DNA Test Population (Thousand), 2011 - 2017
  • Figure 12-6: Sweden - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 - 2024
  • Figure 12-7: Sweden - Cervical Cancer Mortality (Number), 2011 - 2017
  • Figure 12-8: Sweden - Cervical Cancer Test Market (Million US$), 2011 - 2017
  • Figure 12-9: Sweden - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2024
  • Figure 12-10: Sweden - Pap Smear Test Market (Million US$), 2011 - 2017
  • Figure 12-11: Sweden - Forecast for Pap Smear Test Market (Million US$), 2018 - 2024
  • Figure 12-12: Sweden - HPV DNA Test Market (Million US$), 2011 - 2017
  • Figure 12-13: Sweden - Forecast for HPV DNA Test Market (Million US$), 2018 - 2024
  • Figure 13-1: Switzerland - Cervical Cancer Test Population (Thousand), 2011 - 2017
  • Figure 13-2: Switzerland - Forecast for Cervical Cancer Test Population (Thousand), 2018 - 2024
  • Figure 13-3: Switzerland - Cervical Cancer Pap Smear Test Population (Thousand), 2011 - 2017
  • Figure 13-4: Switzerland - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 - 2024
  • Figure 13-5: Switzerland - Cervical Cancer HPV DNA Test Population (Thousand), 2011 - 2017
  • Figure 13-6: Switzerland - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 - 2024
  • Figure 13-7: Switzerland - Cervical Cancer Mortality (Number), 2011 - 2017
  • Figure 13-8: Switzerland - Cervical Cancer Test Market (Million US$), 2011 - 2017
  • Figure 13-9: Switzerland - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2024
  • Figure 13-10: Switzerland - Pap Smear Test Market (Million US$), 2011 - 2017
  • Figure 13-11: Switzerland - Forecast for Pap Smear Test Market (Million US$), 2018 - 2024
  • Figure 13-12: Switzerland - HPV DNA Test Market (Million US$), 2011 - 2017
  • Figure 13-13: Switzerland - Forecast for HPV DNA Test Market (Million US$), 2018 - 2024
  • Figure 14-1: Norway - Cervical Cancer Test Population (Thousand), 2011 - 2017
  • Figure 14-2: Norway - Forecast for Cervical Cancer Test Population (Thousand), 2018 - 2024
  • Figure 14-3: Norway - Cervical Cancer Pap Smear Test Population (Thousand), 2011 - 2017
  • Figure 14-4: Norway - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 - 2024
  • Figure 14-5: Norway - Cervical Cancer HPV DNA Test Population (Thousand), 2011 - 2017
  • Figure 14-6: Norway - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 - 2024
  • Figure 14-7: Norway - Cervical Cancer Mortality (Number), 2011 - 2017
  • Figure 14-8: Norway - Cervical Cancer Test Market (Million US$), 2011 - 2017
  • Figure 14-9: Norway - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2024
  • Figure 14-10: Norway - Pap Smear Test Market (Million US$), 2011 - 2017
  • Figure 14-11: Norway - Forecast for Pap Smear Test Market (Million US$), 2018 - 2024
  • Figure 14-12: Norway - HPV DNA Test Market (Million US$), 2011 - 2017
  • Figure 14-13: Norway - Forecast for HPV DNA Test Market (Million US$), 2018 - 2024
  • Figure 15-1: Netherlands - Cervical Cancer Test Population (Thousand), 2011 - 2017
  • Figure 15-2: Netherlands - Forecast for Cervical Cancer Test Population (Thousand), 2018 - 2024
  • Figure 15-3: Netherlands - Cervical Cancer Pap Smear Test Population (Thousand), 2011 - 2017
  • Figure 15-4: Netherlands - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 - 2024
  • Figure 15-5: Netherlands - Cervical Cancer HPV DNA Test Population (Thousand), 2011 - 2017
  • Figure 15-6: Netherlands - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 - 2024
  • Figure 15-7: Netherlands - Cervical Cancer Mortality (Number), 2011 - 2017
  • Figure 15-8: Netherlands - Cervical Cancer Test Market (Million US$), 2011 - 2017
  • Figure 15-9: Netherlands - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2024
  • Figure 15-10: Netherlands - Pap Smear Test Market (Million US$), 2011 - 2017
  • Figure 15-11: Netherlands - Forecast for Pap Smear Test Market (Million US$), 2018 - 2024
  • Figure 15-12: Netherlands - HPV DNA Test Market (Million US$), 2011 - 2017
  • Figure 15-13: Netherlands - Forecast for HPV DNA Test Market (Million US$), 2018 - 2024
  • Figure 16-1: United States - Cervical Cancer Test Population (Thousand), 2011 - 2017
  • Figure 16-2: United States - Forecast for Cervical Cancer Test Population (Thousand), 2018 - 2024
  • Figure 16-3: United States - Cervical Cancer Pap Smear Test Population (Thousand), 2011 - 2017
  • Figure 16-4: United States - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 - 2024
  • Figure 16-5: United States - Cervical Cancer HPV DNA Test Population (Thousand), 2011 - 2017
  • Figure 16-6: United States - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 - 2024
  • Figure 16-7: United States - Cervical Cancer Mortality (Number), 2011 - 2017
  • Figure 16-8: United States - Cervical Cancer Test Market (Million US$), 2011 - 2017
  • Figure 16-9: United States - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2024
  • Figure 16-10: United States - Pap smear Test Market (Million US$), 2011 - 2017
  • Figure 16-11: United States - Forecast for Pap Smear Test Market (Million US$), 2018 - 2024
  • Figure 16-12: United States - HPV DNA Test Market (Million US$), 2011 - 2017
  • Figure 16-13: United States - Forecast for HPV DNA Test Market (Million US$), 2018 - 2024
  • Figure 17-1: Canada - Cervical Cancer Test Population (Thousand), 2011 - 2017
  • Figure 17-2: Canada - Forecast for Cervical Cancer Test Population (Thousand), 2018 - 2024
  • Figure 17-3: Canada - Cervical Cancer Pap Smear Test Population (Thousand), 2011 - 2017
  • Figure 17-4: Canada - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 - 2024
  • Figure 17-5: Canada - Cervical Cancer HPV DNA Test Population (Thousand), 2011 - 2017
  • Figure 17-6: Canada - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 - 2024
  • Figure 17-7: Canada - Cervical Cancer Mortality (Number), 2011 - 2017
  • Figure 17-8: Canada - Cervical Cancer Test Market (Million US$), 2011 - 2017
  • Figure 17-9: Canada - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2022
  • Figure 17-10: Canada - Pap Smear Test Market (Million US$), 2011 - 2017
  • Figure 17-11: Canada - Forecast for Pap Smear Test Market (Million US$), 2018 - 2024
  • Figure 17-12: Canada - HPV DNA Test Market (Million US$), 2011 - 2017
  • Figure 17-13: Canada - Forecast for HPV DNA Test Market (Million US$), 2018 - 2024
  • Figure 18-1: Japan - Cervical Cancer Test Population (Thousand), 2011 - 2017
  • Figure 18-2: Japan - Forecast for Cervical Cancer Test Population (Thousand), 2018 - 2024
  • Figure 18-3: Japan - Cervical Cancer Pap Smear Test Population (Thousand), 2011 - 2017
  • Figure 18-4: Japan - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 - 2024
  • Figure 18-5: Japan - Cervical Cancer HPV DNA Test Population (Thousand), 2011 - 2017
  • Figure 18-6: Japan - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 - 2024
  • Figure 18-7: Japan - Cervical Cancer Mortality (Number), 2011 - 2017
  • Figure 18-8: Japan - Cervical Cancer Test Market (Million US$), 2011 - 2017
  • Figure 18-9: Japan - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2024
  • Figure 18-10: Japan - Pap Smear Test Market (Million US$), 2011 - 2017
  • Figure 18-11: Japan - Forecast for Pap Smear Test Market (Million US$), 2018 - 2024
  • Figure 18-12: Japan - HPV DNA Test Market (Million US$), 2011 - 2017
  • Figure 18-13: Japan - Forecast for HPV DNA Test Market (Million US$), 2018 - 2024
  • Figure 19-1: Korea - Cervical Cancer Test Population (Thousand), 2011 - 2017
  • Figure 19-2: Korea - Forecast for Cervical Cancer Test Population (Thousand), 2018 - 2024
  • Figure 19-3: Korea - Cervical Cancer Pap Smear Test Population (Thousand), 2011 - 2017
  • Figure 19-4: Korea - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 - 2024
  • Figure 19-5: Korea - Cervical Cancer HPV DNA Test Population (Thousand), 2011 - 2017
  • Figure 19-6: Korea - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 - 2024
  • Figure 19-7: Korea - Cervical Cancer Mortality (Number), 2011 - 2017
  • Figure 19-8: Korea - Cervical Cancer Test Market (Million US$), 2011 - 2017
  • Figure 19-9: Korea - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2024
  • Figure 19-10: Korea - Pap Smear Test Market (Million US$), 2011 - 2017
  • Figure 19-11: Korea - Forecast for Pap Smear Test Market (Million US$), 2018 - 2024
  • Figure 19-12: Korea - HPV DNA Test Market (Million US$), 2011 - 2017
  • Figure 19-13: Korea - Forecast for HPV DNA Test Market (Million US$), 2018 - 2024
  • Figure 20-1: Singapore - Cervical Cancer Test Population (Thousand), 2011 - 2017
  • Figure 20-2: Singapore - Forecast for Cervical Cancer Test Population (Thousand), 2018 - 2024
  • Figure 20-3: Singapore - Cervical Cancer Pap Smear Test Population (Thousand), 2011 - 2017
  • Figure 20-4: Singapore - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 - 2024
  • Figure 20-5: Singapore - Cervical Cancer HPV DNA Test Population (Thousand), 2011 - 2017
  • Figure 20-6: Singapore - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 - 2024
  • Figure 20-7: Singapore - Cervical Cancer Test Market (Million US$), 2011 - 2017
  • Figure 20-8: Singapore - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2024
  • Figure 20-9: Singapore - Pap Smear Test Market (Million US$), 2011 - 2017
  • Figure 20-10: Singapore - Forecast for Pap Smear Test Market (Million US$), 2018 - 2024
  • Figure 20-11: Singapore - HPV DNA Test Market (Million US$), 2011 - 2017
  • Figure 20-12: Singapore - Forecast for HPV DNA Test Market (Million US$), 2018 - 2024
  • Figure 21-1: Malaysia - Cervical Cancer Test Population (Thousand), 2011 - 2017
  • Figure 21-2: Malaysia - Forecast for Cervical Cancer Test Population (Thousand), 2018 - 2024
  • Figure 21-3: Malaysia - Cervical Cancer Pap Smear Test Population (Thousand), 2011 - 2017
  • Figure 21-4: Malaysia - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 - 2024
  • Figure 21-5: Malaysia - Cervical Cancer HPV DNA Test Population (Thousand), 2011 - 2017
  • Figure 21-6: Malaysia - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 - 2024
  • Figure 21-7: Malaysia - Cervical Cancer Test Market (Million US$), 2011- 2017
  • Figure 21-8: Malaysia - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2024
  • Figure 21-9: Malaysia - Pap smear Test Market (Million US$), 2011 - 2017
  • Figure 21-10: Malaysia - Forecast for Pap smear Test Market (Million US$), 2018 - 2024
  • Figure 21-11: Malaysia - HPV DNA Test Market (Million US$), 2011 - 2017
  • Figure 21-12: Malaysia - Forecast for HPV DNA Test Market (Million US$), 2018- 2024
  • Figure 22-1: India - Cervical Cancer Test Population (Thousand), 2011 - 2017
  • Figure 22-2: India - Forecast for Cervical Cancer Test Population (Thousand), 2018 - 2024
  • Figure 22-3: India - Cervical Cancer Pap Smear Test Population (Thousand), 2011 - 2017
  • Figure 22-4: India - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 - 2024
  • Figure 22-5: India - Cervical Cancer HPV DNA Test Population (Thousand), 2011 - 2017
  • Figure 22-6: India - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 - 2024
  • Figure 22-7: India - Cervical Cancer VIA Test Population (Thousand), 2011 - 2017
  • Figure 22-8: India - Forecast for Cervical Cancer VIA Test Population (Thousand), 2018 - 2024
  • Figure 22-9: India - Cervical Cancer Test Market (Million US$), 2011 - 2017
  • Figure 22-10: India - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2024
  • Figure 22-11: India - Pap smear Test Market (Million US$), 2011 - 2017
  • Figure 22-12: India - Forecast for Pap smear Test Market (Million US$), 2018 - 2024
  • Figure 22-13: India - HPV DNA Test Market (Million US$), 2011 - 2017
  • Figure 22-14: India - Forecast for HPV DNA Test Market (Million US$), 2018 - 2024
  • Figure 22-15: India - VIA Test Market (Million US$), 2011 - 2017
  • Figure 22-16: India - Forecast for VIA Test Market (Million US$), 2018 - 2024
  • Figure 23-1: China - Cervical Cancer Test Population (Thousand), 2011 - 2017
  • Figure 23-2: China - Forecast for Cervical Cancer Test Population (Thousand), 2018 - 2024
  • Figure 23-3: China - Cervical Cancer Pap Smear Test Population (Thousand), 2011 - 2017
  • Figure 23-4: China - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 - 2024
  • Figure 23-5: China - Cervical Cancer HPV DNA Test Population (Thousand), 2011 - 2017
  • Figure 23-6: China - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 - 2024
  • Figure 23-7: China - Cervical Cancer VIA Test Population (Thousand), 2011 - 2017
  • Figure 23-8: China - Forecast for Cervical Cancer VIA Test Population (Thousand), 2018 - 2024
  • Figure 23-9: China - Cervical Cancer Test Market (Million US$), 2011 - 2017
  • Figure 23-10: China - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2024
  • Figure 23-11: China - Pap smear Test Market (Million US$), 2011 - 2017
  • Figure 23-12: China - Forecast for Pap Smear Test Market (Million US$), 2018 - 2024
  • Figure 23-13: China - HPV DNA Test Market (Million US$), 2011 - 2017
  • Figure 23-14: China - Forecast for HPV DNA Test Market (Million US$), 2018 - 2024
  • Figure 23-15: China - VIA Test Market (Million US$), 2011 - 2017
  • Figure 23-16: China - Forecast for VIA Test Market (Million US$), 2018 - 2024
  • Figure 24-1: Thailand - Cervical Cancer Test Population (Thousand), 2011 - 2017
  • Figure 24-2: Thailand - Cervical Cancer Test Population (Thousand), 2018 - 2024
  • Figure 24-3: Thailand - Cervical Cancer Pap Smear Test Population (Thousand), 2011 - 2017
  • Figure 24-4: Thailand - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 - 2024
  • Figure 24-5: Thailand - Cervical Cancer VIA Test Population (Thousand), 2011 - 2017
  • Figure 24-6: Thailand - Forecast for Cervical Cancer VIA Test Population (Thousand), 2018 - 2024
  • Figure 24-7: Thailand - Cervical Cancer Test Market (Million US$), 2011 - 2017
  • Figure 24-8: Thailand - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2024
  • Figure 24-9: Thailand - Pap smear Test Market (Million US$), 2011 - 2017
  • Figure 24-10: Thailand - Forecast for Pap Smear Test Market (Million US$), 2018 - 2024
  • Figure 24-11: Thailand - VIA Test Market (Million US$), 2011 - 2017
  • Figure 24-12: Thailand - Forecast for VIA Test Market (Million US$), 2018 - 2024
  • Figure 25-1: Indonesia - Cervical Cancer Test Population (Thousand), 2011 - 2017
  • Figure 25-2: Indonesia - Forecast for Cervical Cancer Test Population (Thousand), 2018 - 2024
  • Figure 25-3: Indonesia - Cervical Cancer Pap Smear Test Population (Thousand), 2011 - 2017
  • Figure 25-4: Indonesia - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 - 2024
  • Figure 25-5: Indonesia - Cervical Cancer HPV DNA Test Population (Thousand), 2011 - 2017
  • Figure 25-6: Indonesia - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 - 2024
  • Figure 25-7: Indonesia - Cervical Cancer VIA Test Population (Thousand), 2011 - 2017
  • Figure 25-8: Indonesia - Forecast for Cervical Cancer VIA Test Population (Thousand), 2018 - 2024
  • Figure 25-9: Indonesia - Cervical Cancer Both (Pap smear & VIA) Test Population (Thousand), 2011 - 2017
  • Figure 25-10: Indonesia - Forecast for Cervical Cancer Both (Pap smear & VIA) Test Population (Thousand), 2018 - 2024
  • Figure 25-11: Indonesia - Cervical Cancer Test Market (Million US$), 2011 - 2017
  • Figure 25-12: Indonesia - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2024
  • Figure 25-13: Indonesia - Pap Smear Test Market (Million US$), 2011 - 2017
  • Figure 25-14: Indonesia - Forecast for Pap Smear Test Market (Million US$), 2018 - 2024
  • Figure 25-15: Indonesia - HPV DNA Test Market (Million US$), 2011 - 2017
  • Figure 25-16: Indonesia - Forecast for HPV DNA Test Market (Million US$), 2018 - 2024
  • Figure 25-17: Indonesia - VIA Test Market (Million US$), 2011 - 2017
  • Figure 25-18: Indonesia - Forecast for VIA Test Market (Million US$), 2018 - 2024
  • Figure 25-19: Indonesia - Both (Pap smear & VIA) Test Market (Million US$), 2011 - 2017
  • Figure 25-20: Indonesia - Forecast for Both (Pap smear & VIA) Test Market (Million US$), 2018 - 2024
  • Figure 26-1: Rest of World - Cervical Cancer Test Population (Thousand), 2011 - 2017
  • Figure 26-2: Rest of World - Forecast for Cervical Cancer Test Population (Thousand), 2018 - 2024
  • Figure 26-3: Rest of World - Cervical Cancer Pap Smear Test Population (Thousand), 2011 - 2017
  • Figure 26-4: Rest of World - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2018 - 2024
  • Figure 26-5: Rest of World - Cervical Cancer HPV DNA Test Population (Thousand), 2011 - 2017
  • Figure 26-6: Rest of World - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 - 2024
  • Figure 26-7: Rest of World - Cervical Cancer Test Market (Million US$), 2011 - 2017
  • Figure 26-8: Rest of World - Forecast for Cervical Cancer Test Market (Million US$), 2018 - 2024
  • Figure 26-9: Rest of World - Pap Smear Test Market (Million US$), 2011 - 2017
  • Figure 26-10: Rest of World - Forecast for Pap Smear Test Market (Million US$), 2018 - 2024
  • Figure 26-11: Rest of World - HPV DNA Test Market (Million US$), 2011 - 2017
  • Figure 26-12: Rest of World - Forecast for HPV DNA Test Market (Million US$), 2018 - 2024

List of Tables:

  • Table 5-1: Global -Cervical Cancer Test Population Share (Percent) By Country, 2011 - 2017
  • Table 5-2: Global - Forecast for Cervical Cancer Test Population Share (Percent) by Country, 2018 - 2024
  • Table 6-1: Global - Cervical Cancer Test Market Share (Percent) by Country, 2011 - 2017
  • Table 6-2: Global - Forecast for Cervical Cancer Test Market Share (Percent) by Country, 2018 - 2024
  • Table 6-3: Global - Pap Smear Test Market Share (Percent), 2011 - 2017
  • Table 6-4: Global - Forecast for Pap Smear Test Market Share (Percent), 2018 - 2024
  • Table 6-5: Global - HPV DNA Test Market Share (Percent), 2011 - 2017
  • Table 6-6: Global - Forecast for HPV DNA Test Market Share (Percent), 2018 - 2024
  • Table 6-7: Global - VIA Test Market Share (Percent), 2011 - 2017
  • Table 6-8: Global - Forecast for VIA Test Market Share (Percent), 2018 - 2024
  • Table 26-1: Worldwide - List of Countries which offer VIA Test via National Programs, 2015
  • Table 26-2: Worldwide - List of Countries which offer VIA Test via Pilot Programs, 2015
  • Table 26-3: Worldwide - Prevalence of HPV 16/18 in Women with Normal Cervical Cytology (Percent), 2014 - 2015
  • Table 26-4: United Kingdom - Number of Incidence Observed and Projected and their respective Age Standardized Rate, 2010 - 2025
  • Table 26-5: Worldwide - Prevalence (Percent) of Young Women (15-44 Years) who Have Sex before the Age of 15 Years, 1994 - 2006
Back to Top